Lina Khan, FTC chair (Graeme Jennings/Pool via AP Images)
June 17, 2022 06:53 AM EDT
Pharma

FTC tar­gets in­sulin, threat­en­ing to go af­ter PBM-phar­ma deals that steer in­to 'com­mer­cial bribery'

Zachary Brennan

Senior Editor

The Fed­er­al Trade Com­mis­sion vot­ed unan­i­mous­ly yes­ter­day (5-0) to adopt a new pol­i­cy specif­i­cal­ly tar­get­ing ris­ing in­sulin prices, but al­so putting …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times